| Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets JM Balko, JM Giltnane, K Wang, LJ Schwarz, CD Young, RS Cook, ... Cancer discovery 4 (2), 232-245, 2014 | 568 | 2014 |
| Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance JM Balko, RS Cook, DB Vaught, MG Kuba, TW Miller, NE Bhola, ... Nature medicine 18 (7), 1052-1059, 2012 | 322 | 2012 |
| Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital database CS Vallejos, HL Gómez, WR Cruz, JA Pinto, RR Dyer, R Velarde, ... Clinical breast cancer 10 (4), 294-300, 2010 | 294 | 2010 |
| Characteristics of gastric cancer around the world MJ López, J Carbajal, AL Alfaro, LG Saravia, D Zanabria, JM Araujo, ... Critical Reviews in Oncology/Hematology 181, 103841, 2023 | 166 | 2023 |
| Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy? JA Pinto, CS Vallejos, LE Raez, LA Mas, R Ruiz, JS Torres-Roman, ... ESMO open 3 (3), e000344, 2018 | 163 | 2018 |
| Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence Science Translational Medicine 8 (334), 334ra53, 2016 | 152 | 2016 |
| Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer JB Dennison, JR Molina, S Mitra, AM González-Angulo, JM Balko, ... Clinical Cancer Research 19 (13), 3703-3713, 2013 | 136 | 2013 |
| DNA damage inducible transcript 4 gene: the switch of the metabolism as potential target in cancer I Tirado-Hurtado, W Fajardo, JA Pinto Frontiers in oncology 8, 106, 2018 | 106 | 2018 |
| Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer JM Araujo, AC Gomez, A Aguilar, R Salgado, JM Balko, L Bravo, F Doimi, ... Scientific reports 8 (1), 4899, 2018 | 98 | 2018 |
| Automatic breast density classification using a convolutional neural network architecture search procedure P Fonseca, J Mendoza, J Wainer, J Ferrer, J Pinto, J Guerrero, ... Medical imaging 2015: computer-aided diagnosis 9414, 556-563, 2015 | 94 | 2015 |
| In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies JA Pinto, C Rolfo, LE Raez, A Prado, JM Araujo, L Bravo, W Fajardo, ... Scientific reports 7 (1), 1526, 2017 | 75 | 2017 |
| Resistencia antimicrobiana de uropatógenos en adultos mayores de una clínica privada de Lima, Perú J Miranda, J Pinto, M Faustino, B Sánchez-Jacinto, F Ramirez Revista Peruana de Medicina Experimental y Salud Pública 36, 87-92, 2019 | 63 | 2019 |
| Control of cervical cancer in Peru: Current barriers and challenges for the future (Review) A Aguilar, JA Pinto, J Araujo, W Fajardo, L Bravo, L Pinillos, C Vallejos Molecular and Clinical Oncology, 2016 | 53 | 2016 |
| ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer G Rosas, R Ruiz, JM Araujo, JA Pinto, L Mas Critical reviews in oncology/hematology 136, 48-55, 2019 | 50 | 2019 |
| Lung cancer in the young M Galvez-Nino, R Ruiz, JA Pinto, K Roque, R Mantilla, LE Raez, L Mas Lung 198 (1), 195-200, 2020 | 47 | 2020 |
| Barriers in Latin America for the management of locally advanced breast cancer JA Pinto, L Pinillos, C Villarreal-Garza, Z Morante, MV Villarán, G Mejía, ... Ecancermedicalscience 13, 2019 | 46 | 2019 |
| The impact of COVID-19 in the healthcare workforce in Peru J Neyra-León, J Huancahuari-Nuñez, JC Díaz-Monge, JA Pinto Journal of Public Health Policy 42 (1), 182, 2020 | 44 | 2020 |
| A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease JA Pinto, J Araujo, NK Cardenas, Z Morante, F Doimi, T Vidaurre, ... NPJ genomic medicine 1 (1), 1-7, 2016 | 43 | 2016 |
| Impact of the delayed initiation of adjuvant chemotherapy in the outcome of triple negative breast cancer Z Morante, R Ruiz, JM Araujo, JA Pinto, G de la Cruz-Ku, ... Clinical Breast Cancer 21 (3), 239-246. e4, 2021 | 41 | 2021 |
| Telemedicine and the current opportunities for the management of oncological patients in Peru in the context of COVID-19 pandemic P Montenegro, L Pinillos, F Young, A Aguilar, I Tirado-Hurtado, JA Pinto, ... Critical Reviews in Oncology/Hematology 157, 103129, 2021 | 35 | 2021 |
Henry GomezOncoSalud/AUNA (Lima, Peru)gecoperu.org üzerinde doğrulanmış e-posta adresine sahip